Although the data from the previous study suggests that HAI-2 has an inhibitory role in matriptase-elicited proteolytic cascade65, there is a lack of direct evidence to demonstrate HAI-2 as a cognate inhibitor of matriptase in human prostate cancer. This evidence concerns the gene ST14 and prostate carcinoma.